As part of the Resolution Membership Program, collectors will receive 15% off all submissions, expedited turnaround times, ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for this GPCR stock update.

Utah land managers released a new map, outlining nearly 60,000 "high risk" wildland urban interface structures all over the ...

Since its inception, Freddie Mac’s Single-Family CRT program has transferred approximately $118 billion of credit risk on ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...

Over the past five years, the attorney general’s office, with Aaron Frey at the helm, has secured for Maine more than $260 million in settlements with major pharmaceutical companies accused of ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Vibe coding sounds effortless, until it isn't. Building a full iPhone app with Claude Code showed me why baby steps, backups, and testing matter.

The agency that negotiated the opioid settlements has the fewest reporting requirements. Here’s how it’s spending its money.

The fund seeks to enable researchers to make leaps rather than incremental advances in the natural sciences and engineering.